Can longstanding constipation be associated with muscular dystrophy or other muscle and mitochondrial disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Association Between Longstanding Constipation and Muscular Dystrophy/Mitochondrial Disorders

Yes, longstanding constipation can be associated with muscular dystrophy and mitochondrial disorders, as these conditions can affect gastrointestinal smooth muscle function and motility.

Muscular Dystrophy and GI Dysfunction

  • Muscular dystrophies are frequently associated with gastrointestinal motility disorders, including chronic constipation and more severe conditions like intestinal pseudo-obstruction 1
  • Duchenne muscular dystrophy (DMD) specifically has been linked to GI smooth muscle dysfunction, which can manifest as gastroparesis, intestinal dysmotility, and constipation 2
  • In myotonic dystrophy, there are documented cases of chronic intestinal pseudo-obstruction (CIPOS), which represents a severe form of GI dysmotility 3

Mitochondrial Disorders and GI Dysfunction

  • Mitochondrial disorders are relatively common in patients with chronic intestinal pseudo-obstruction (CIPO) - one study showed 19% of adult patients labeled as CIPO had mitochondrial disorders 2
  • Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is characterized by severe gastrointestinal dysmotility, with recurrent diarrhea and symptoms of obstruction 2
  • Patients with MNGIE typically present between the first and third decade of life and have gastrointestinal dysmotility as the most prominent manifestation 2

Diagnostic Approach for Suspected Cases

When longstanding constipation raises suspicion for muscular dystrophy or mitochondrial disorders, consider:

  1. Initial screening tests:

    • Screen for hypothyroidism, coeliac disease, and diabetes 2
    • Assess for proximal muscle weakness and check muscle enzyme levels 4
  2. Specific tests for mitochondrial disorders:

    • Plasma and urine thymidine and deoxyuridine
    • White blood cell thymine phosphorylase
    • Testing for the TYMP gene
    • Screening for related diseases like MELAS (mitochondrial encephalopathy with lactic acidosis and stroke-like episodes) 2
  3. Advanced diagnostic procedures:

    • Muscle biopsy and sequencing of mitochondrial genome 2
    • MRI brain can be helpful in the diagnosis of MNGIE 2
    • Full thickness jejunal biopsy to assess enteric nerves and muscle 2

Pathophysiological Mechanisms

  • In muscular dystrophies, gastrointestinal dysmotility occurs due to dysfunction of gastrointestinal smooth muscle 5
  • Mitochondrial dysfunction leads to inflammation, fibrosis, and metabolic anomalies that can affect gut function 6
  • The gut-muscle axis may be involved in the spread of inflammatory signals to muscles in muscular dystrophies 6
  • Intestinal dysbiosis can modulate the metabolic state, immune response, and mitochondrial biogenesis in muscular dystrophies 6

Clinical Considerations and Management

  • Patients with DMD require special attention to GI function, particularly in perioperative settings, as they may have increased risk of complications 2
  • Management approaches include:
    • Bowel regimens to avoid and treat constipation 2
    • Consideration of prokinetic GI medications 2
    • Gastric decompression with a nasogastric tube in patients with severe GI dysmotility 2
    • Nutritional support if oral feeding is compromised 2

Common Pitfalls and Caveats

  • Constipation alone is not diagnostic of muscular dystrophy or mitochondrial disorders - look for additional neurological or systemic symptoms 2
  • GI dysmotility in these disorders can range from mild constipation to life-threatening conditions like intestinal pseudo-obstruction and volvulus 1
  • Medications used to treat other symptoms in these patients (particularly pain medications) can exacerbate constipation 2
  • Mitochondrial disorders are often underdiagnosed and should be considered in patients with unexplained constellation of symptoms involving seemingly unrelated organs 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Autophagy Impairment in Muscular Dystrophy Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Neuromuscular disease of the gastrointestinal tract.

The American journal of the medical sciences, 1991

Research

The Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis.

International journal of molecular sciences, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.